Melinda Hoff's Contact Details

Melinda Hoff's Company Details

ABC2

Washington, DC, US • 5 - 9 Employees
Market Research

ABC2 (Accelerate Brain Cancer Cure) is focused on speeding brain cancer breakthroughs. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC2 closes current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC2's partners range from medical research centers to early-stage biotechnology companies to large multi-national pharmaceutical companies. These partners all share a vision of driving translational research and moving treatments as fast as possible from basic discovery to the clinic. Since brain cancer affects a relatively small portion of the population, ABC2 recognizes the importance of investing in the early stages of the most novel sectors of the discovery and development pipeline in order to "buy down the risk" for our partners and speed progress of innovative new treatments to the clinic.